Rosuvastatin helps stave off contrast nephropathy in NSTE-ACS patients  

出　　处：《South China Journal of Cardiology》2013年第1期87-88,共2页岭南心血管病杂志（英文版）

摘　　要：Key points： PRATO-ACS randomized NSTE-ACS patients to rosuvastatin or control prior to PCI Statin resulted in significant decrease in nephropathy, better short-term outcomes Data needed to elucidate class effects of statins, causalityKey points： PRATO-ACS randomized NSTE-ACS patients to rosuvastatin or control prior to PCI Statin resulted in significant decrease in nephropathy, better short-term outcomes Data needed to elucidate class effects of statins, causality

关 键 词：ACS Rosuvastatin helps stave off contrast nephropathy in NSTE-ACS patients 

分 类 号：R692.9[医药卫生—泌尿科学]